Keywords: Obesity
The U.S. Food and Drug Administration (FDA) has accepted for review multiple applications from China’s Hybio Pharmaceutical for a generic version of a widely used GLP-1 class drug, the company said in a stock exchange filing on Tuesday. The applications relate to an abbreviated new drug application......
The American healthcare company CVS Health has announced that it will reinstate insurance coverage for Eli Lilly’s obesity treatment Zepbound, marking a significant shift in its pharmacy benefit policies. The decision was made by CVS Caremark, the company’s pharmacy benefit management division,......
France is set to begin reimbursing weight-loss medications for severely obese patients starting in mid-June, according to Health Minister Stéphanie Rist. The decision marks a significant step in the country’s public health strategy to address rising obesity rates and improve access to modern......
Fast food consumption is expanding rapidly across Morocco, reshaping eating habits and raising growing concerns about public health, nutrition and the future of traditional cuisine. What was once an occasional indulgence has become a routine part of daily life for many young people and urban families. Burgers,......
The Eli Lilly and Co weight-loss pill has received approval from the U.S. Food and Drug Administration, marking a major step in the growing market for oral obesity treatments. The drug, called orforglipron and marketed under the brand name Foundayo, becomes the second pill-based option available in the......
Climate change may worsen public health in the United States by increasing the consumption of sugary foods and drinks, according to a new study published Monday. Researchers warn that higher temperatures encourage Americans to consume more sodas, juices, and frozen desserts, especially among lower-income......
Energy drinks, a popular choice among teenagers, could soon be off-limits for those under 16 in England. The British government announced plans to ban the sale of these products to minors in an effort to “improve the physical and mental health” of young people and tackle rising obesity rates. According......
New research presented at the European Society of Cardiology annual conference in Madrid suggests that weight loss drugs known as GLP-1 agonists could dramatically reduce the risk of hospitalisation and premature death in patients with heart conditions. The study analysed real-world data from over 90,000......
Obesity is emerging as a significant health concern in Morocco, affecting an increasing number of adults each year. According to the latest World Obesity Atlas report, released on March 4 in conjunction with World Obesity Day, 59% of Moroccan adults currently have a body mass index (BMI) exceeding 25......
-
20:00
-
19:21
-
19:05
-
18:45
-
18:30
-
18:15
-
18:00
-
17:43
-
17:25
-
17:10
-
16:45
-
16:26
-
16:12
-
16:10
-
16:02
-
15:50
-
15:47
-
15:32
-
15:23
-
15:19
-
15:15
-
15:00
-
14:44
-
14:28
-
14:26
-
14:22
-
14:10
-
14:02
-
13:47
-
13:41
-
13:37
-
13:30
-
13:15
-
13:08
-
13:00
-
12:42
-
12:27
-
12:21
-
12:05
-
11:45
-
11:38
-
11:28
-
11:11
-
10:47
-
10:44
-
10:32
-
10:26
-
10:23
-
10:15
-
10:01
-
09:58
-
09:57
-
09:45
-
09:44
-
09:42
-
09:21
-
09:06
-
09:05
-
08:45
-
08:25
-
08:19
-
08:10
-
08:05
-
07:47
-
07:31
-
07:15
